ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)

South Korea flag South Korea · Delayed Price · Currency is KRW
981.00
-57.00 (-5.49%)
At close: Feb 13, 2026
Market Cap30.39B -3.2%
Revenue (ttm)60.50B -1.6%
Net Income-7.66B
EPS-246.82
Shares Out30.98M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume405,335
Average Volume1,084,308
Open1,031.00
Previous Close1,038.00
Day's Range948.00 - 1,037.00
52-Week Range873.00 - 1,420.00
Beta0.52
RSI52.22
Earnings DateMar 13, 2026

About KOSDAQ:034940

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers i... [Read more]

Industry Pharmaceutical Preparations
Founded 1964
Employees 269
Stock Exchange KOSDAQ
Ticker Symbol 034940
Full Company Profile

Financial Performance

In 2024, KOSDAQ:034940's revenue was 62.69 billion, a decrease of -0.44% compared to the previous year's 62.97 billion. Losses were -9.60 billion, -8.65% less than in 2023.

Financial Statements